Panel Session:

AI Revolution in Clinical Denials Management: Provider Insights from Groundbreaking Pilot Program

Today’s healthcare landscape can be daunting. Payers are now using AI to deny legitimate claims in as little as 2 seconds, leaving providers struggling to manage an overwhelming tide of appeals necessary to recover rightful payments.

In response to this challenge, Aspirion has developed groundbreaking AI technology that automatically generates comprehensive appeal letters by extracting relevant clinical evidence aligned with coding guidelines, clinical protocols, and specific payer policies—further extending attorney and clinical capabilities.

Listen in as revenue cycle leaders from Banner Health, Houston Methodist, and Legacy Health share first-hand insights into their experiences in Aspirion’s AI pilot program, including the transformative outcomes achieved and their vision for the future of AI in healthcare finance.

Session Duration: 53 Minutes

See How Our AI Works

Short on Time?

Jump straight to the insights. Below are the seven questions that drove our panel discussion, featuring panelist perspectives and strategic discussions on AI in clinical denials management.

Meet The Panelists

Katie LeBlanc

Chief Revenue Cycle Officer,

Banner Health

Lisa Schillaci

Vice President, Revenue Cycle,

Houston Methodist

Terrie Handy

Vice President, Chief Revenue Cycle Officer,
Legacy Health

Jim Bohnsack

Chief Strategy and Client Officer,

Aspirion

“I like Aspirion a lot. They are bringing AI into everything, so that is good. They are trying to leverage the existing technologies that are out there today and acquiring smaller companies that are helping them enable the processes faster for us. I’m excited about those upcoming changes that are part of the firm’s strategic vision.”

Director
July 2024, Collected by KLAS Research